An open label Phase 1 safety and tolerability study of omadacycline and tigecycline in healthy adults.

Trial Profile

An open label Phase 1 safety and tolerability study of omadacycline and tigecycline in healthy adults.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 May 2017

At a glance

  • Drugs Omadacycline (Primary) ; Tigecycline
  • Indications Acute sinusitis; Anthrax; Community-acquired pneumonia; Nosocomial infections; Skin and soft tissue infections; Urinary tract infections
  • Focus Adverse reactions
  • Most Recent Events

    • 02 May 2017 New trial record
    • 25 Apr 2017 According to a Paratek Pharmaceuticals Media Release, data was presented at the annual meeting of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2017)
    • 25 Apr 2017 Results published in a Paratek Pharmaceuticals Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top